[34], [35] It is being also appreciated that SSRIs can exert beneficial effects on IBS, with particular regard for the control of abdominal discomfort or pain, [16], [36] but whether SERT polymorphisms may influence such therapeutic responses remains unknown. The gene discussed is SLC6A4; the disease is irritable bowel syndrome.